Xenograft tumor growth was significantly reduced in Scrib-OE cells compared to control cells (Figure 5I–5K), suggesting that Scrib inhibited the growth of HCC cells in vivo. This evidence concerns the gene SCRIB and hepatocellular carcinoma.